Suvizumab
Jump to navigation
Jump to search
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Humanized |
Target | HIV-1 |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
(what is this?) (verify) |
This article provides insufficient context for those unfamiliar with the subject.(April 2021) |
Suvizumab is an antiviral and immunomodulator. It binds to HIV-1.[1]
References
- ^ "Proposed List number 102 of International Nonproprietary Names" (PDF). WHO Drug Information. 23 (4). Geneva: World Health Organization: 344. 2009. ISSN 1010-9609.
Categories:
- Articles with short description
- Short description is different from Wikidata
- Drugs not assigned an ATC code
- Articles with changed CASNo identifier
- Chemicals that do not have a ChemSpider ID assigned
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugs that are a monoclonal antibody
- Wikipedia articles needing context from April 2021
- All Wikipedia articles needing context
- All pages needing cleanup
- Monoclonal antibodies
- Experimental antiviral drugs
- All stub articles
- Antiinfective agent stubs
- Monoclonal antibody stubs